ERA4TB to accelerate the development of comprehensive treatments against tuberculosis

(Universidad Carlos III de Madrid) Accelerating the development of antibiotics against all forms of tuberculosis is the objective of ERA4TB (European Regimen Accelerator for Tuberculosis), one of the largest European scientific projects in this area of research. This consortium, which includes a significant number of Spanish researchers, is being coordinated by the Universidad Carlos III de Madrid (UC3M), led by GlaxoSmithKline Spain and is under the scientific management of the Pasteur Institute.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news